120 related articles for article (PubMed ID: 38340582)
1. NAA10 gene expression is associated with mesenchymal transition, dedifferentiation, and progression of clear cell renal cell carcinoma.
Duong NX; Nguyen T; Le MK; Sawada N; Kira S; Kondo T; Inukai T; Mitsui T
Pathol Res Pract; 2024 Mar; 255():155191. PubMed ID: 38340582
[TBL] [Abstract][Full Text] [Related]
2. NAA10 overexpression dictates distinct epigenetic, genetic, and clinicopathological characteristics in adult gliomas.
Le MK; Vuong HG; Nguyen TTT; Kondo T
J Neuropathol Exp Neurol; 2023 Jun; 82(7):650-658. PubMed ID: 37253389
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
[TBL] [Abstract][Full Text] [Related]
4. Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature.
Nallandhighal S; Vince R; Karim R; Groves S; Stangl-Kremser J; Russell C; Hu K; Pham T; Cani AK; Liu CJ; Zaslavsky A; Mehra R; Cieslik M; Morgan TM; Palapattu GS; Udager AM; Salami SS
Eur Urol Oncol; 2022 Feb; 5(1):92-99. PubMed ID: 34840106
[TBL] [Abstract][Full Text] [Related]
5. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
Filipović J; Bosić M; Ćirović S; Životić M; Dunđerović D; Đorđević D; Živković-Perišić S; Lipkovski A; Marković-Lipkovski J
Diagn Pathol; 2019 Oct; 14(1):120. PubMed ID: 31655611
[TBL] [Abstract][Full Text] [Related]
6. NAA10 promotes proliferation of renal cell carcinoma by upregulating UPK1B.
Zhang ZY; Zhang JL; Zhao LX; Yang Y; Guo R; Zhou N; Liu YR; Zheng GP
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11553-11560. PubMed ID: 33275221
[TBL] [Abstract][Full Text] [Related]
7. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
[TBL] [Abstract][Full Text] [Related]
8. RP11-367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial-mesenchymal transition.
Shao IH; Peng PH; Wu HH; Chen JL; Lai JC; Chang JS; Wu HT; Wu KJ; Pang ST; Hsu KW
Cancer Med; 2023 Apr; 12(8):9788-9801. PubMed ID: 36847128
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma.
Xiao W; Wang X; Wang T; Xing J
Cancer Gene Ther; 2020 May; 27(5):330-340. PubMed ID: 31155610
[TBL] [Abstract][Full Text] [Related]
10. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
[TBL] [Abstract][Full Text] [Related]
11. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
12. MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Meng L; Gao J; Mo W; Wang B; Shen H; Cao W; Ding M; Diao W; Chen W; Zhang Q; Shu J; Dai H; Guo H
Redox Biol; 2023 Dec; 68():102956. PubMed ID: 37977044
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma.
Song J; Song F; Liu K; Zhang W; Luo R; Tang Y; Ran L
Aging (Albany NY); 2019 Nov; 11(22):10316-10337. PubMed ID: 31743108
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of NEBL promotes migration and invasion of clear cell renal cell carcinoma by inducing epithelial-mesenchymal transition.
Zhao R; Liang Z; Chu J; Zheng Q; Zhao J; Tang S; Chen Q; Huang Y; Zhou X; Pan X
Pathol Res Pract; 2024 Feb; 254():155068. PubMed ID: 38215565
[TBL] [Abstract][Full Text] [Related]
15. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
16. LIMD2 promotes tumor proliferation, invasion, and epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Zhong QY; Xie YW; Chen ZL; Chen YQ; Liu YX; Xie WL; Yan W
Neoplasma; 2022 Jul; 69(4):832-840. PubMed ID: 35532296
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
[TBL] [Abstract][Full Text] [Related]
18. LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Ning L; Li Z; Wei D; Chen H; Yang C
Cancer Biomark; 2017; 19(1):75-83. PubMed ID: 28269753
[TBL] [Abstract][Full Text] [Related]
19. Construction of an Epithelial-Mesenchymal Transition-Related Model for Clear Cell Renal Cell Carcinoma Prognosis Prediction.
Zhu S; Wu T; Ji Z; Wu Z; Lin H; Shen C; Yang Y; Zheng Q; Hu H
Dis Markers; 2022; 2022():3780391. PubMed ID: 35983409
[TBL] [Abstract][Full Text] [Related]
20. HAO2 inhibits malignancy of clear cell renal cell carcinoma by promoting lipid catabolic process.
Xiao W; Wang X; Wang T; Chen B; Xing J
J Cell Physiol; 2019 Dec; 234(12):23005-23016. PubMed ID: 31127626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]